scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1044999287 |
P356 | DOI | 10.1186/1476-4598-13-24 |
P932 | PMC publication ID | 3928084 |
P698 | PubMed publication ID | 24495306 |
P5875 | ResearchGate publication ID | 260093214 |
P50 | author | Adriana Franco Paes Leme | Q29460228 |
Isadora Luana Flores | Q42290132 | ||
Fernando M Simabuco | Q56440959 | ||
Edgard Graner | Q56811390 | ||
Michelle Agostini | Q57205097 | ||
Annelize Z B Aragão | Q130272462 | ||
Sami Yokoo | Q130272463 | ||
P2093 | author name string | Romênia R Domingues | |
Ricardo Della Coletta | |||
Daniela C Granato | |||
Rebeca Kawahara | |||
Carolina C S Macedo | |||
Lucas Miguel | |||
P2860 | cites work | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway | Q21735927 |
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells | Q24301702 | ||
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance | Q24645668 | ||
The ADAM metalloproteinases | Q28292696 | ||
ADAMs: key components in EGFR signalling and development | Q28305519 | ||
Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration | Q28482278 | ||
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips | Q29614831 | ||
Andromeda: a peptide search engine integrated into the MaxQuant environment | Q29615816 | ||
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF | Q29619098 | ||
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
Identification of novel interaction between ADAM17 (a disintegrin and metalloprotease 17) and thioredoxin-1. | Q30415770 | ||
Role of ADAMs in cancer formation and progression | Q33410732 | ||
Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1 | Q33639024 | ||
ADAM-17: the enzyme that does it all. | Q33737421 | ||
iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS | Q34247201 | ||
ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis | Q34515863 | ||
Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. | Q34577446 | ||
Oral cancer: Current role of radiotherapy and chemotherapy. | Q34647980 | ||
ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction | Q34751406 | ||
Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. | Q34781580 | ||
Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. | Q36129113 | ||
Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion | Q36510571 | ||
The ADAMs: signalling scissors in the tumour microenvironment | Q37324256 | ||
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer | Q37442339 | ||
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 | ||
Advances and applications of oral cancer basic research. | Q37908644 | ||
Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer | Q37995693 | ||
ERK1/2 MAP kinases: structure, function, and regulation | Q38008550 | ||
Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR. | Q38696292 | ||
miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer | Q39172569 | ||
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation | Q39214664 | ||
ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion | Q39422039 | ||
ADAM17 promotes glioma cell malignant phenotype | Q39561009 | ||
The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. | Q39911126 | ||
Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9. | Q39977866 | ||
SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells | Q40519854 | ||
The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme | Q40525523 | ||
ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site | Q42382724 | ||
Hemorrhagic activity of HF3, a snake venom metalloproteinase: insights from the proteomic analysis of mouse skin and blood plasma | Q43514772 | ||
Analysis of the subproteomes of proteinases and heparin-binding toxins of eight Bothrops venoms | Q44061073 | ||
Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma | Q46093042 | ||
Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis | Q48534691 | ||
MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE | Q50554929 | ||
IKKβ overexpression leads to pathologic lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia. | Q51428903 | ||
Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. | Q51774418 | ||
Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions. | Q54377971 | ||
Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A | Q84502004 | ||
ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway | Q84752497 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P921 | main subject | murine model | Q122890741 |
P304 | page(s) | 24 | |
P577 | publication date | 2014-02-05 | |
P1433 | published in | Molecular Cancer | Q15724585 |
P1476 | title | ADAM17 mediates OSCC development in an orthotopic murine model | |
P478 | volume | 13 |
Q89001809 | Agrin has a pathological role in the progression of oral cancer |
Q64071566 | CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p |
Q30278389 | Integrative analysis to select cancer candidate biomarkers to targeted validation |
Q92808114 | MicroRNA-224, negatively regulated by c-jun, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma |
Q64119426 | Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma |
Q37148314 | Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis |
Search more.